Avalon Consolidates Its CAR-T Enterprise By Forming Subsidiary Avactis Biosciences
Avalon GloboCare Corp. is a global intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high impact, transformative cell-based /technologies and their clinical applications, as well as healthcare facility management through its core platforms, namely "Avalon...
Biobanking Science: Biobank Sperm Without Liquid Nitrogen
With gene editing technology such as CRISPR, it is becoming quicker and easier to generate disease models for medical research. Researchers around the world use tens of thousands of different mouse lines. Research institutions can save money and reduce...
Asterias Expands The Indication Exploration Scope For AST-OPC1 Cell Therapy
Asterias Biotherapeutics, Inc. is a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated with demyelination and cellular immunotherapies to treat cancer. Asterias is presently focused on advancing three clinical-stage programs which have the potential to...
FDA Grants Nohla Therapeutics’ Cell Therapy Dilanubicel Orphan Drug Designation for HSCT
Nohla Therapeutics, headquartered in Seattle, is a leading developer of “off-the shelf” cell therapies for patients with cancer and other diseases. Nohla’s proprietary notch ligand technology platform serves as the foundation for its ongoing clinical, preclinical and discovery programs....
Biobanking Consent: Informing Human Subjects of the Possibilities
As researchers, we are familiar with why we have the need for biobanking regulations due to the story of Henrietta Lacks. HeLa cells survived in vitro more than 60 years ago and are still contributing to medical science advancements.1...
Cell Therapy – New Method To Reprogram T-cells Without Viral Vectors Developed At UCSF
A new method has been developed, primarily by University of California San Francisco (UCSF) researcher Theo Roth of Alex Marson’s laboratory, to introduce gene editing CRISPR technology into T-cells without the use of viral vectors. The method was published...
Biobanking Science: HIV RNA Stable at -80°C in Biobanks
Biobanks facilitate research by collecting, storing and sharing samples. One of the major concerns that biobanks face is how to best maintain sample quality over long time periods. The AIDS Clinical Trial Group (ACTG) is one of biggest groups...
ARMADA, The Antibiotic Resistance Monitoring, Analysis And Diagnostics Alliance Biobank
ARMADA, is the Antibiotic Resistance Monitoring, Analysis and Diagnostics Alliance. It will be a publicly supported Global Biobank that will, for the first time, combine big-data and rapid bacteria tracking approaches to create a virtual “shield” against multi-drug resistant...
BC Platforms And Tieto Partner To Advance Precision Medicine For Nordic Healthcare Providers
BC Platforms, founded in 1997 from an MIT Whitehead project spinoff, is in the business of powerful genomic data management and analysis solutions. The company operates a global network of biobanks known as BCRQUEST.COM, which provides genomic and clinical...
Biotime Has Licensed One Of Its Pluripotent Cell Lines To GoLiver
BioTime Inc. is a clinical-stage biotechnology company, headquartered in the San Francisco Bay Area, focused on degenerative diseases. Its clinical programs are based on two platform technologies: cell replacement and cell/drug delivery. With its cell replacement platform, BioTime is...
